Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBLE) in Northern France:: a five-year multicentre incidence study

被引:63
作者
Albertini, MT [1 ]
Astagneau, P [1 ]
Benoit, C [1 ]
Berardi, L [1 ]
Berrouane, Y [1 ]
Boisivon, A [1 ]
Cahen, P [1 ]
Cattoen, C [1 ]
Costa, Y [1 ]
Darchis, P [1 ]
Delière, E [1 ]
Demontrond, D [1 ]
Eb, F [1 ]
Golliot, F [1 ]
Grise, G [1 ]
Harel, A [1 ]
Koeck, JL [1 ]
Lepennec, MP [1 ]
Malbrunot, C [1 ]
Marcollin, M [1 ]
Maugat, S [1 ]
Nouvellon, M [1 ]
Pangon, B [1 ]
Ricouart, S [1 ]
Roussel-Delvallez, M [1 ]
Vachée, A [1 ]
Carbonne, A [1 ]
Marty, L [1 ]
Jarlier, V [1 ]
机构
[1] C CLIN Nord, Inst Cordeliers, F-75006 Paris, France
关键词
antibiotic resistance; epidemiology; prevention; surveillance; nosocomial;
D O I
10.1053/jhin.2002.1286
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In order to measure the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and of Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE), and to evaluate the impact of the national guidelines for multidrug-resistant bacteria (MDRB) prevention in hospitals of Northern France, a multicentre survey was conducted for three months every year starting in 1996, in volunteer hospital laboratories. All clinical specimens positive for MRSA and ESBLE were prospectively surveyed. During the five-year surveillance period, the overall proportion of MRSA was 38.4% in the 28 534 strains of S. aureus, and that of ESBLE was 11.4% in the 6121 strains of Klebsiella pneumoniae and 47.7% in the 2353 strains of Enterobacter aerogenes. The overall incidence rates of clinical specimens positive for MRSA, ESBL-K. pneumoniae and E. aerogenes were 0.84, 0.05 and 0.12/1000 hospital-days (HD), respectively. In the 23 hospitals that participated in the survey every year, the proportion and incidence of MRSA increased from 35.6 to 41.0% and from 0.71 to 0.96/1000 HD (P < 0.001). Conversely, the incidence of ESBLE decreased. Hence, despite recommendations as for isolation precautions, MRSA remains poorly controlled and requires more effective measures. (C) 2002 The Hospital Infection Society.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 35 条
[1]   Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey [J].
Astagneau, P ;
Fleury, L ;
Leroy, S ;
Lucet, JC ;
Golliot, F ;
Régnier, B ;
Brücker, G .
JOURNAL OF HOSPITAL INFECTION, 1999, 42 (04) :303-312
[2]   Organization of hospital-acquired infection control in France [J].
Astagneau, P ;
Brücker, G .
JOURNAL OF HOSPITAL INFECTION, 2001, 47 (02) :84-87
[3]   Prevalence of nosocomial infections in France:: results of the nationwide survey in 1996 [J].
Astagneau, P ;
Branger, B ;
Dumartin, C ;
Gayet, S ;
Lepoutre, A ;
Parneix, P ;
Savey, A ;
Bientz, M ;
Brücker, G ;
Carlet, J ;
Chaperon, J ;
Lejeune, B ;
Cullet, D ;
Fabry, J ;
Golliot, F ;
Gulian, C ;
Jacquelinet, C ;
Labadie, JC ;
Sartor, C ;
Kadi, Z ;
Gachie, JP .
JOURNAL OF HOSPITAL INFECTION, 2000, 46 (03) :186-193
[4]   Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: Roles of an infection control program and changes in aminoglycoside use [J].
AubryDamon, H ;
Legrand, P ;
BrunBuisson, C ;
Astier, A ;
Soussy, CJ ;
Leclercq, R .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :647-653
[5]  
Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6
[6]  
BOYCE JM, 1994, INFECT CONT HOSP EP, V15, P105
[7]   INTESTINAL DECONTAMINATION FOR CONTROL OF NOSOCOMIAL MULTIRESISTANT GRAM-NEGATIVE BACILLI - STUDY OF AN OUTBREAK IN AN INTENSIVE-CARE UNIT [J].
BRUNBUISSON, C ;
LEGRAND, P ;
RAUSS, A ;
RICHARD, C ;
MONTRAVERS, F ;
BESBES, M ;
MEAKINS, JL ;
SOUSSY, CJ ;
LEMAIRE, F .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (11) :873-881
[8]  
BUCHOLZ U, 2001, P 11 EUR C CLIN MICR
[9]  
BUIRMA RJA, 1991, SCAND J INFECT DIS, P35
[10]   Methicillin-resistant Staphylococcus aureus in the community:: New battlefronts, or are the battles lost? [J].
Cookson, BD .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (06) :398-403